Altria Group, Inc. stands as the largest tobacco company in the United States, focused solely on the domestic market after spinning off Philip Morris International (PM) in 2008. Through its Philip Morris USA subsidiary, Altria controls Marlboro, which accounts for roughly 42% of the U.S. cigarette retail market. It also leads in machine-made cigars with Black & Mild and in moist smokeless tobacco via Copenhagen and Skoal, while expanding its smoke-free offerings through the on! nicotine pouch brand and the NJOY e-vapor business. Altria maintains an equity stake in Anheuser-Busch InBev (BUD). Investors track the stock for its robust cash generation, elevated dividend yield, and consistent capital returns, set against the backdrop of declining cigarette volumes and ongoing regulatory considerations.
Over the past 30 days, MO rose approximately 15.7%, advancing from a September 30 close of $67.34 to around $77.90. The steepest gains came after the third-quarter earnings release. The shares held near $67 in late September before climbing steadily through mid-October and then jumping again following the October 29 results.
The three-month view shows a comparable recovery with added volatility. Starting from $67.94 on July 30, the stock dipped to a multi-month low near $64 in mid-August before regaining ground through September and surging in October. Across the full quarter, MO posted gains of roughly 14.7%, driven by the rebound from the August low and a positive re-rating after the earnings and capital return updates.
The primary catalyst was Altria’s third-quarter 2026 earnings release on October 29. Adjusted diluted EPS came in at $1.52, a 4.8% year-over-year increase that topped the $1.51 consensus, while net revenues grew 1.0% to $6.13 billion. Revenues net of excise taxes advanced 3.6% to $5.44 billion, aided by pricing in the smokeable products segment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Alongside the beat, management lifted full-year 2026 adjusted EPS guidance to $5.66–$5.74, pointing to 4.5%–6.0% growth from the 2025 base of $5.42. The board approved a $1 billion expansion of the share repurchase program through December 31, 2027. During the quarter, Altria bought back 5.9 million shares for about $400 million and distributed $1.7 billion in dividends.
Further support came from the smoke-free portfolio, where on! nicotine pouch shipments increased 13.3% year over year to 47.8 million cans, along with Marlboro’s stronger positioning in the premium segment. Combined with the stock’s high dividend yield and defensive profile, these elements sustained buying interest through October.
The quarterly gain reflects a broader recovery story. After falling to roughly $64 in mid-August, shares regained momentum as investors favored stable, high-yield consumer staples amid economic uncertainty. The August dividend increase underscored Altria’s long track record of shareholder returns, while consistent execution in smokeable products highlighted ongoing pricing power despite industry-wide volume declines.
Progress in the smoke-free transition also shaped sentiment over the three months. Growth in on! pouches and continued investment in NJOY and flavor innovation indicate Altria is adapting beyond traditional cigarettes, even as Marlboro remains central to segment economics. Regulatory developments, including litigation aimed at streamlining the FDA authorization process, stayed on investors’ radar without interrupting the upward move.
Looking forward, key items to monitor include fourth-quarter and full-year results plus any early commentary on 2027 expectations, especially the start of an agreement with Philip Morris International slated to contribute next year. Regulatory outcomes remain relevant: Altria and its subsidiaries have pursued legal steps toward a more efficient FDA product-authorization process, and the status of NJOY’s return to the e-vapor market will draw attention.
Additional factors encompass the pace of cigarette volume declines amid inflation and pressure on consumer spending, competitive dynamics in the nicotine pouch category, and the durability of dividend and buyback programs. While pricing strength and reliable cash flow have been evident, continued execution in smoke-free products and a stable regulatory setting will be central to maintaining confidence. This analysis is informational and does not constitute investment advice.
In reviewing stocks like Altria, I often look at Tickeron’s AI Trading Bots to see how different automated approaches might align with the company’s profile. The platform curates top-performing strategies across hundreds of bots, allowing comparison of varying timeframes and risk parameters without relying on any single method.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day RSI Indicator for MO moved out of overbought territory on November 02, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 instances where the indicator moved out of the overbought zone. In 23 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a move down at 52%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MO as a result. In 31 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 38%.
The Moving Average Convergence Divergence Histogram (MACD) for MO turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 22 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 47%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 35%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where MO advanced for three days, in 225 of 390 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
MO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 127 of 291 cases where MO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 44%.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MO's P/B Ratio (-47.639) is very low in comparison to the industry average of (-7.297). P/E Ratio (16.025) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (2.649) is also within normal values, averaging (3.595). Dividend Yield (0.058) settles around the average of (0.060) among similar stocks. MO's P/S Ratio (5.744) is slightly higher than the industry average of (2.780).
The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 29 (best 1 - 100 worst), indicating outstanding price growth. MO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company which produces and markets tobacco products
Industry Tobacco